Case Series of Methylene Blue Injections for the Treatment of Zygapophysial and Sacroiliac Joint Pain: Results of 5 Cases

DOI: 10.4236/ojanes.2013.36066   PDF   HTML     4,264 Downloads   6,156 Views   Citations

Abstract

Introduction: Shealy is credited with the use of fluoroscopy guided radiofrequency ablation (RFA) for denervation of the lumbar zygapophysial (L-Z) joint in the mid-1970’s. Peng and colleagues described the use of methylene blue (MB) injection for discogenic pain; MB may work through direct neurotoxicity or inhibition of nitric oxide synthesis. We present a retrospective case series of five patients with L-Z or SI joint pain where MB used as an alternative to RFA. Materials and Methods: This is a retrospective case series of five patients who received MB for the chemical neurolysis of either medial or/and lateral branch’s for zygapophysial or SI joint pain. All of the MB blocks were done under fluoroscopic guidance and performed in the same manner as diagnostic medial and lateral branch blocks but with care to consider the medication as neurotoxic in relation to spinal nerves. On average 1cc of 0.05% final concentration MB was injected per nerve or sacral foraminal level. Results: Four of the five patients had significant lasting pain relief. Discussion: Chemical neurolysis has potential to achieve technical success in these refractory cases of spine pain possibly due to spread over a broader area; for this same reason the procedure should be performed carefully under fluoroscopic guidance.

Share and Cite:

J. Parekh, M. Eckmann and S. Ramamurthy, "Case Series of Methylene Blue Injections for the Treatment of Zygapophysial and Sacroiliac Joint Pain: Results of 5 Cases," Open Journal of Anesthesiology, Vol. 3 No. 6, 2013, pp. 301-303. doi: 10.4236/ojanes.2013.36066.

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1] S. P. Cohen and S. N. Raja, “Pathogenesis, Diagnosis, and Treatment of Lumbar Zygapophysial Joint Pain,” Anesthesiology, Vol. 106, No. 3, 2007, pp. 591-614. doi:10.1097/00000542-200703000-00024
[2] P. Dreyfuss, B. Halbrook, K. Pauza, A. Joshi, J. McLarty and N. Bogduk, “Efficacy and Validity of Radiofrequency Neurotomy for Chronic Lumbar Zygapophysial Joint Pain,” Spine, Vol. 25, No. 10, 2000, pp. 1270-1277. doi:10.1097/00007632-200005150-00012
[3] S. M. Lord, L. Barnsley, B. J. Wallis, G. J. McDonald and N. Bogduk, “Percutaneous Radio-Frequency Neurotomy for Chronic Cervical Zygapophyseal-Joint Pain,” The New England Journal of Medicine, Vol. 335, 1996, pp. 1721-1726. doi:10.1056/NEJM199612053352302
[4] B. Peng, Y. Zhang, S. Hou, W. Wu and X. Fu, “Intradiscal Methylene Blue Injection for the Treatment of Chronic Discogenic Low Back Pain,” European Spine Journal, Vol. 16, No. 1, 2007, pp. 33-38. doi:10.1007/s00586-006-0076-1
[5] P. J. Poppers, A. R. Mastri, M. Lebeaux and B. G. Covino, “The Effect of Methylene Blue on Neural Tissue,” Anesthesiology, Vol. 33, No. 3, 1970, pp. 335-340. doi:10.1097/00000542-197009000-00014
[6] B. B. Mentes, M. Akin, S. Leventoglu, F. A. Gultekin and M. Oguz, “Intradermal Methylene Blue Injection for the Treatment of Intractable Idiopathic Pruritus Ani: Results of 30 Cases,” Techniques in Coloproctology, Vol. 8, No. 1, 2004, pp. 11-14. doi:10.1007/s10151-004-0043-y
[7] P. J. Christo and D. Mazloomdoost, “Interventional Pain Treatments for Cancer Pain,” Annals of the New York Academy of Sciences, Vol. 1138, 2008, pp. 299-328. doi:10.1196/annals.1414.034
[8] R. H. Schirmer, B. Coulibaly, A. Stich, M. Scheiwein, H. Merkle, J. Eubel, K. Becker, H. Becher, O. Müller, T. Zich, W. Schiek and B. Kouyaté, “Methylene Blue as an Antimalarial Agent,” Redox Report, Vol. 8, No. 5, 2003, pp. 272-276. doi:10.1179/135100003225002899
[9] M. Salah, N. Samy and M. Fadel, “Methylene Blue Mediated Photodynamic Therapy for Resistant Plaque Psoriasis,” Journal of Drugs in Dermatology, Vol. 8, No. 1, 2009, pp. 42-49.
[10] J. P. Tardivo, A. Del Giglio, L. H. Paschoal and M. S. Baptista, “New Photodynamic Therapy Protocol to Treat AIDS-Related Kaposi’s Sarcoma,” Photomedicine and Laser Surgery, Vol. 24, No. 4, 2006, pp. 528-531. doi:10.1089/pho.2006.24.528
[11] J. F. Papin, R. A. Floyd and D. P. Dittmer, “Methylene Blue Photoinactivation Abolishes West Nile Virus Infectivity in Vivo,” Antiviral Research, Vol. 68, No. 2, 2005, pp. 84-87. doi:10.1016/j.antiviral.2005.07.001

  
comments powered by Disqus

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.